Semaglutide's most frequently reported adverse effects are gastrointestinal in nature, occurring in a dose-dependent manner
When you reconstitute the peptide, you should never shake the vial vigorously
Semaglutide (Ozempic) is a GLP-1 medication designed to support weight loss by reducing appetite, controlling cravings, and promoting sustainable fat loss
Tell your healthcare provider if you are taking any of the following medicines: Other stimulant medications, such as Adderall (dextroamphetamine/amphetamine) or Dexedrine (dextroamphetamine) MAOIs, such as Marplan (isocarboxazid), Zyvox (linezolid), Nardil (phenelzine), and Parnate (tranylcypromine)as mentioned above, however, your healthcare provider will likely tell you not to take Vyvanse until at least 14 days after taking MAOIs Some dietary supplements, such as vitamin C (ascorbic acid) Some antacids, such as Soda Mint (sodium bicarbonate) Some laxatives, such as Dulcolax (bisacodyl) Call your healthcare provider about all prescription and non-prescription medicines, vitamins, and herbal products you are taking before starting taking Vyvanse
The Green List is FDAs trusted lane for GLP1 API manufacturers FDA calls 6680 a green list import alert in its consumer-facing GLP1 warning page
Soreness or Tenderness: Feeling a bit sore at the injection site is not unusual, especially for the first few injections